The Group Company has successfully won the bid for the Roche (Shanghai) Biopharmaceutical Production Base Project.


The Group Company has successfully won the bid for the Roche (Shanghai) Biopharmaceutical Production Base Project.

Recently, good news came from the Shanghai market: the Group has successfully won the bid for the Roche (Shanghai) Biopharmaceutical Production Base Project (Phase I), with a contract value exceeding 120 million yuan. The Roche (Shanghai) Biopharmaceutical Production Base serves as a core strategic pillar for the Roche Group in the Asia-Pacific region, featuring massive total investment and extremely stringent technical standards—placing rigorous demands on contractors’ overall performance capabilities, cleanroom process expertise, and safety management systems. The Maosheng International Engineering Branch, responsible for construction, is the Group’s premier team in the field of high‑end biopharmaceutical industrial engineering, boasting absolute advantages in professional expertise, technological prowess, and talent development. This ensures that construction tasks are completed to the highest standards and with the utmost quality, with the goal of establishing the project as a benchmark in the biopharmaceutical industry and further enhancing the Qian’an brand in the foreign‑invested biopharmaceutical sector. (Shanghai Company)

Recommended news


The Group dispatched representatives to attend the Exchange Meeting on Construction Project Quality and Safety Management and the On-site Observation Session.

In late September, the China Construction Enterprise Management Association organized an experience-sharing and on-site observation conference on quality and safety management in construction projects in Guangzhou, which was attended by representatives from the Group.


Empowering Communities Through Health: Experts Bring Science-Based Education to Qian’an

On September 18, Jiangsu Qian’an Construction Group, in collaboration with the Science Education Base of Qidong People’s Hospital, hosted the 2026 National Science Popularization Event.


Benchmarking against global standards! The Jotun Zhangjiagang project has successfully passed the safety audit conducted by its Norwegian headquarters.

In mid-September, a foreign‑owned expert audit team from Jotun’s Norwegian headquarters conducted a three‑day, headquarter‑level specialized safety audit on the Jotun Zhangjiagang project site undertaken by the Group.


The Roche (Shanghai) project of the Group has successfully achieved 2 million safe man-hours.

On September 17, the Roche (Shanghai) Biopharmaceutical Production Base project, undertaken by the Group, successfully reached the milestone of 2 million safe man-hours.


The Group dispatched personnel to attend the training on building trustworthy quality teams in chemical engineering construction.

On September 16–17, the China Chemical Construction Enterprises Association held a training course on building “Quality‑Trusted Work Teams” in Chengdu, with representatives from the Group in attendance. The session featured a live lecture by Shi Jie, a senior expert of the Association.


Good News Abounds | The Group Has Secured Multiple Emerging Industry Projects in Succession

In the golden autumn season, bountiful harvests abound, and new‑generation growth sectors showcase their strength. Since August, leveraging its deep-rooted expertise and core competencies in industrial installation, the Group has successively won bids for five key projects in emerging productivity fields, with a total contract value exceeding RMB 250 million, injecting robust momentum into its resilient year‑end performance.